Modified lipid nanoparticles for targeted mRNA delivery to the brain
Penn Engineers have modified lipid nanoparticles (LNPs) -; the revolutionary technology behind the COVID-19 mRNA vaccines -; to not only cross the blood-brain barrier (BBB) but also to target specific…